This brain mapping and LED therapy innovation was unveiled at CES 2021 in January.
South Korean start-up iMediSync has designed a digital electroencephalography (EEG) helmet for early detection of Alzheimer's disease through its cloud-based Artificial Intelligence (AI) platform. This innovation was announced last year; however the launch is pending approval from the U.S. Food and Drug Administration (FDA).
Among the features of this device are the non-use of conductive gel to perform an EEG, as well as making it easier for users to perform regular check-ups for the prevention of neurodegenerative disorders. It is also a device that can be easily transported and its brain mapping technology includes LED photobiomodulation.
“AI brain mapping with EEG discovers Alzheimer's brainwave and could detect pre-clinical Alzheimer's dementia (AD). With AI analytics and brain mapping techniques, it can also serve personalized NIR-LED neuromodulation using the iSyncWave headset to enhance neuronal activity,” explains the company on its official site. Brain waves slow down over time, although it is difficult to detect, through AI and deep learning this process becomes more accurate.
“iSyncWave works with iSyncMe - a mobile application that connects to iMediSync's cloud platform, iSyncBrain, the AI-driven EEG analysis platform for precision mental care. iSyncMe also works as a telemedicine platform connecting iSyncWave's user to online doctors or mental care specialists.”
The South Korean start-up is currently conducting research work for the development of treatments for Attention Deficit Hyperactivity Disorder (ADHD), depression, Parkinson's disease and other neurological conditions.
